Stay updated on Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.

Latest updates to the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPublication source description changed from 'These publications come from PubMed... automatically created by ClinicalTrials.gov Identifier (NCT Number)' to 'These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study', and the revision tag updated from v3.2.0 to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedRemoved the banner notice about lapse in government funding and potential data delays. The notice previously directed users to cc.nih.gov and opm.gov for operating status updates.SummaryDifference0.4%

- Check49 days agoChange DetectedNo core content changes were detected; only minor formatting or wording tweaks appear. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check70 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference3%

- Check77 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software/version release with no evident changes to core content or functionality.SummaryDifference0.1%

- Check92 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2 and the Back to Top element was removed; no substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.